proceeding

App_3162/2024 UPC_CFI_14/2023

App_3162/2024 - Application to amend a patent

2023

Munich central division - First Instance

Date of Filing: 24/01/24

Registry Numbers: App_3162/2024 UPC_CFI_14/2023

Case Title:

Patents

EP3666797

Patents

EP3666797

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Parties

Applicant 1. Amgen Inc.
Defendant 2. Regeneron Pharmaceuticals Inc.